Adoptive immunotherapy of established syngeneic solid tumors: role of T lymphoid subpopulations.
Open Access
- 1 April 1984
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 132 (4) , 2117-2122
- https://doi.org/10.4049/jimmunol.132.4.2117
Abstract
We have investigated the subpopulations of T cells necessary to mediate the cure of established tumors in two models of successful adoptive immunotherapy. In C57BL/6 mice bearing palpable and disseminated FBL-3 lymphoma, both Lyt-1+ and Lyt-2+ cells played a major role in mediating the regression and permanent cure of mice, whereas in BALB/c mice bearing the Meth A sarcoma the adoptive transfer of Lyt-1+2+ cells played a major role in mediating the regression of tumors and the curing of disease. Identical experiments performed in hybrid (BALB/c X C57BL/6) mice yielded similar results, further supporting our initial observation and indicating that in these two adoptive transfer model systems it is the tumor and not the variable expression of Lyt antigens by the host that determines which T cell subpopulation is required to cure mice of tumors.This publication has 22 references indexed in Scilit:
- Cells mediating graft rejection in the mouse. I. Lyt-1 cells mediate skin graft rejection.The Journal of Experimental Medicine, 1981
- A simplified method for the production of murine T-cell growth factor free of lectinJournal of Immunological Methods, 1981
- Lyt-2-/Lyt 3- variants of a cloned cytolytic T cell line lack an antigen receptor functional in cytolysis.The Journal of Experimental Medicine, 1981
- THE ROLE OF T-CELL SETS IN THE REJECTION OF A METHYLCHOLANTHRENE-INDUCED SARCOMA (S1509A) IN SYNGENEIC MICE1981
- Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes.The Journal of Experimental Medicine, 1980
- Fractionation of lymphocyte populations with monoclonal antibodies specific for LYT-2.2 and LYT-3.1.The Journal of Immunology, 1980
- T cell-mediated immunity to oncornavirus-induced tumors. II. Ability of different T cell sets to prevent tumor growth in vivo.The Journal of Immunology, 1980
- T-cell-mediated suppression of anti-tumor immunity. An explanation for progressive growth of an immunogenic tumor.The Journal of Experimental Medicine, 1980
- Role of Different T Cell Sets in the Rejection of Syngeneic Chemically Induced TumorsThe Journal of Immunology, 1979
- INVITRO GROWTH OF MURINE T-CELLS .2. GROWTH OF INVITRO SENSITIZED CELLS CYTOTOXIC FOR ALLOANTIGENS1978